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Abstract: Drug interactions with phospholipid bilayers underpin their 
behaviour in cell membranes and in liposomal delivery formulations.  
Liposomal drug delivery in ocular medicine can overcome the physical 
barriers of the eye and better enable the active molecule to reach its 
target.  Here, Raman and 19F solid-state NMR spectroscopy are used 
to characterise the interactions of two ocular corticosteroid drugs, 
difluprednate (DFP) and fluorometholone (FML), with multilamellar 
vesicles of phosphatidylcholine (PC).  31P NMR confirms that the lipid 
bilayer tolerates a high drug concentration (a drug: lipid molar ratio of 
1:10). The 19F NMR spectra of the drugs in lipid bilayers reveal that 
FML and DFP have different average orientations within the lipid 
bilayer.  Raman spectra of dried lipid films reveal that PC separates 
from DFP but not from FML, the less lipophilic of the two drugs. This 
combined approach will assist the design of, and inform the 
development of, improved liposomal preparations.    
Introduction 
Understanding the structural and dynamic properties of 
lipophilic and amphiphilic pharmaceuticals within phospholipid 
bilayers is fundamentally important for assessing their 
bioavailability and pharmacokinetics and for optimising liposomal 
drug delivery systems.[1]   The partitioning of drugs into cellular 
membranes, diffusion within the lipid bilayer and subsequent 
egress into the cellular environment all influence their ability to 
reach the pharmacological targets.[2] Drug encapsulation by 
liposomes can be advantageous for improving cellular uptake, 
enhancing biodistribution and increasing drug stability, and has 
impacted many areas of biomedicine.[3]  One therapeutic area in 
which liposomal drug delivery has attracted interest is in ocular 
medicine, as a means of overcoming several physical barriers to 
drugs reaching their targets on the anterior and posterior of the 
eye.[4]  In order for drugs to be absorbed into the eye, effective 
corneal penetration and prolonged contact are required, both of 
which liposomal drug delivery can enhance due to the 
bioavailability and low toxicity of liposomes.[5]  Intravitreal injection 
of drug-loaded liposomes has been shown to significantly 
increase the available concentrations and therapeutic half-life of 
drugs in the eye.[6] For example, corticosteroids drugs for 
treatment of edema, inflammation and angiogenic eye diseases 
have been delivered to the eye with nanostructured lipid 
carriers.[7]  
 
Figure 1.  Chemical structures of two corticosteroid drugs. The steroid rings are 
labelled A-D. 
In this work, 19F solid-state NMR and vibrational Raman 
spectroscopy are used to examine the interactions of two 
corticosteroid drugs (Figure 1)  with model 
palmitoyloleoylphosphatidylcholine (POPC) multilamellar vesicles 
(MLVs). Difluprednate (DFP) is a difluorinated drug used for the 
treatment of post-operative ocular inflammation and pain and was 
approved by the US Food and Drug Administration in 2008.  
Fluoromethalone (FML) is another ocular anti-inflammatory drug, 
which has the same steroidal ring structure as DFP but with a 
single fluorine substituent and a shorter aliphatic tail. 19F NMR 
spectra on hydrated vesicles report the average orientation of the 
drugs within lipid bilayers and their effects on the structure and 
stability of the lipid bilayer. Raman analysis is carried out on films 
of dried lipid vesicles containing the drugs, to establish how the 
drying process (used to preserve liposome stability) affects the 
drug distribution. This information is of use when developing new 
lipid formulations of the drug.   
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Results and Discussion 
Solid-state NMR analysis of DFP in hydrated vesicles 
Static 31P solid state NMR was used to establish whether the DFP 
is accommodated within the lipid bilayers without disrupting the 
lamellar organisation of the vesicles. Spectra of hydrated POPC 
vesicles alone and with a 10-fold molar excess of DFP (Figure 2a) 
exhibit line shapes that are typical for a lipid bilayer.[8] The virtually 
identical widths (~45 ppm) and lineshapes of the two spectra 
indicate that DFP does not perturb the lipid headgroups 
significantly and that the MLVs tolerate a high concentration of the 
drug without disruption of the overall lamellar structure.  The two 
fluorine substituents of the steroid ring enable 19F NMR 
characterisation of the behaviour of the drug within the lipid 
bilayers.  The 2D magic-angle spinning (MAS) 19F NMR spectrum 
of pure solid DFP exhibits  several overlapping peaks at around -
172 ppm assigned to F28 and fully- or partially- resolved peaks 
around -192 ppm assigned to F29 (Figure 2b).  The F28 - F29 
cross-peaks resolve at least 5 pairs of chemical shifts (Table S1), 
consistent multiple crystalline forms of the drug having different 
conformations.[9]  The average of the measured static powder 
chemical shift anisotropy (CSA) values, st, for F28 and F29 are 
19.4 and -30.2 ppm (Table S2). The 19F NMR spectrum of DFP in 
POPC membranes (obtained without sample spinning) exhibits 
single peaks for F28 and F29 with substantially reduced chemical 
shift anisotropies compared to the solid state (Figure 2c and Table 
S3).  The peak narrowing signifies rapid anisotropic averaging of 
the chemical shift tensors (Figure S1), by motions including 
internal conformational fluctuations and rotational diffusion of the 
drug within the lipid bilayer.  Peak fitting yielded the 19F chemical 
shift parameters for F28 and F29 (Figure 2c and Table S3), 
including the dynamically-averaged CSA values, av. An 
asymmetry parameter  of zero for both nuclei indicates a  
 
Figure 2. NMR analysis of DFP in POPC bilayers. (a) Static 31P NMR spectra 
of POPC membranes alone (black) and in the presence of DFP at a lipid: drug 
molar ratio of 10:1 (blue).  The asterisk denotes a small narrow component in 
the POPC-only spectrum (< 3 % of the overall signal) attributed to small, rapidly 
tumbling lipid assemblies that often form spontaneously during sample 
preparation. (b) 2D 19F-19F dipolar correlation spectrum and horizontal projection 
of solid DFP at a MAS frequency of 12 kHz.  (c) Static, proton-decoupled 19F 
NMR spectrum of 10:1 POPC:DFP membranes overlaid with the best fitting 
simulated spectra, from which were obtained values of the motionally-averaged 
anisotropy, av, of -1.8 ppm for F28 and +4.3 ppm for F29.  
 
Figure 3. Analysis of the individual 19F chemical shift data for DFP in POPC 
membranes. (a) The drug undergoes anisotropic rotation about a principal axis 
(black arrow) that is on average parallel with the bilayer normal, and additional 
motional fluctuations or “wobble” of the rotation axis away from the bilayer 
normal represented by order parameter Smol. The predicted orientations of the 
F28 and F29 chemical shift principal axes are represented by red, green and 
blue lines.(b) Angles FR and FR define the orientation of the rotational axis 
relative to the principal axes xx, yy and zz of the asymmetric 19F chemical shift 
tensors for F28 and F29. (c) Contour plots in which the solid lines indicate the 
experimentally consistent ranges of av values (-2.0 ppm ≥ av ≥ -1.0 ppm for 
F28 and 5.0 ppm ≥ av ≥ 4.0 ppm for F29) calculated from combinations of FR 
and FR angles.  An order parameter, Smol, of 0.8 is assumed.   
symmetrical CSA tensor as a result of nanosecond rotational  
diffusion about an axis that is, on average, parallel with the bilayer 
normal.  Further, the absence of sharp isotropic components to 
the line shapes confirms that that DFP partitions fully into the 
anisotropic environment of the lipid bilayer.  
The average orientation of DFP in POPC bilayers 
Further analysis of the 19F chemical shift parameters for DFP in 
lipid bilayers was carried out to determine the dynamically 
averaged orientation of the drug. The 19F NMR line shapes of 
fluorinated molecules in lipid bilayers are sensitive to their 
average orientation about the main axis of rotational diffusion.[10]  
The measured anisotropy, av, is a function of azimuthal angle 
FR and polar angle FR, which define the orientation of the 
molecular rotational axis in a given 19F CSA principal axis system 
(Figure 3, a and b).  The relationship is given by[11]  
∆δav=0.5Smol Δδst (3cos2 β – 1 – ηsin2βFRcos2αFR)    [1] 
Smol is an order parameter representing the amplitude of 
excursions of the rotational axis from the bilayer normal by angle 
, where Smol = cos   Any pair of [FR, FR] angles can be 
translated into a particular drug orientation in the bilayer if it is 
known how the 19F chemical shift tensor principal axes, xx, yy and 
zz, are directed relative to the molecular geometry.  The principal 
axis orientations were here determined from density functional 
theory calculations on the DFP conformation from the crystal 
structure after optimisation. It was assumed that the crystal 
structure represents the average conformation of the drug within 
the lipid bilayer.  The static and averaged 19F CSA parameters,  




Figure 4.  Restricted molecular orientations of DFP in POPC bilayers obtained 
by combined analysis of the calculated av values for F28 and F29. (a) An 
arbitrary molecular coordinate system is defined relative to the geometry of DFP 
(only rings A and B are shown for clarity).  The orientation of the rotational axis 
in the molecular frame is defined by angles MR and MR. (b)  All possible 
orientations of the rotational axis in the molecular frame are sampled by 
varying MR and MR from 0-180°, and av values for F28 and F29 are calculated 
for each orientation.  Contoured regions show sum-of-square (SS) values that 
represent acceptable agreement between the calculated and measured av 
values (SS < 5.0 ppm2). An order parameter, Smol, of 0.8 is assumed.  
measured by spinning side-band fitting to the solid-state NMR 
spectrum at 5 kHz MAS (Table S3; Figure S2), were substituted 
into Eq [1] and FR and FR were each varied from 0 – 180° to find 
the angles that give av values close to those measured for F28 
(-1.8 ppm) and F29 (4.3 ppm).  Whilst a restricted range of FR 
values are calculated for F28 and F29, all possible values of FR 
are permitted (Figure 3c).  Analysis of av for each 19F nucleus 
independently of the other cannot therefore determine the drug 
orientation.   
An alternative approach was used in which the F28 and F29 
CSA data were analysed simultaneously to exploit the different 
orientations of the F28 and F29 chemical shift tensor axes with 
respect to the molecular geometry. An arbitrary molecular 
coordinate system was defined in which the z axis lies along the 
C3=O bond and the x axis is normal to the plane of ring A (Figure 
4a).  The orientation of the principal rotation axis in this new 
reference frame is defined by angles MR and MR.   These angles 
were varied from 0 – 180° and, for each orientation, av was 
calculated for F28 and F29. The contour plot in Figure 4b shows 
the angle combinations giving calculated av values for both F28 
and F29 within an acceptable range of the measured values.  It is 
seen that there are just 3 distinct groups of drug orientations that 
are consistent with the measured av values for F28 and F29. 
Group [1] is defined by MR values of 0° ± 5°, but MR takes all 
possible values. However, because the rotation axis is close to 
the z axis of the reference frame, the uncertainty in MR has little 
impact on the drug orientation, which is upright in the lipid bilayer 
(Figure 5a).  In orientations [2] and [3], the fused ring system of 
the drug is approximately perpendicular to the bilayer normal 
(Figure 5a). With the exception of  MR for group [1], the range of 
angles describing each orientational group covers about 10°. The 
spread of angles depends to some extent on the choice of Smol in 
the calculation.  A value of 0.8 was used in this case, but lower or 
higher values are seen to decrease or increase the certainty in  
the orientation (Table S4). 
It is intuitive to assume that group [1] represents the most 
favourable average orientation of DFP because the volume 
occupied by the drug in an upright position is less likely to disrupt 
the lipid bilayer than if the drug were to penetrate the bilayer  
 
Figure 5. Determination of the average molecular orientation of DFP in POPC 
bilayers.  (a) Representative orientations from each group, [1], [2] and [3], 
relative to the rotational axis (blue arrow), which is parallel with the bilayer 
normal. The axis of rotation is shown in the 19F CSA principal axis system for 
F29, with the origin at the molecular centre of mass.  (b)  Proton-coupled static 
19F spectrum of DFP in POPC bilayers (black) overlaid with simulated proton-
coupled line shapes (red) for the average orientations shown above each 
spectrum. 
perpendicularly to the bilayer normal. However, groups [2] and [3] 
cannot be ruled out from the chemical shift data alone.   To 
attempt to identify the correct orientation from the three groups, 
orientationally-dependent 1H-19F dipolar couplings were analysed 
from the lineshape of a proton-coupled 19F NMR spectrum (Figure 
5b). The line shapes of the two peaks for F28 and F29 are 
influenced by intramolecular 1H-19F dipolar couplings, dav, which 
are averaged by rotational diffusion according to 
[19]dav = 0.5 dst(3cos2 – 1)       [2] 
The static dipolar coupling, dst, is dependent on the 1H-19F 
distance and  is the angle between the dipolar vector and the 
rotational axis.  Simulated line shapes were calculated for F28 
and F29 using the same CSA parameters in Table S1 but 
including dipolar couplings to all protons within 5 Å of each 19F 
nucleus (i.e., corresponding to dst values of 904 Hz or higher).  
The simulation for orientation [1] is clearly in much closer 
agreement with the spectrum than are the simulations for the 
other orientations (Figure 5b) and hence the spectrum is 
consistent with the favoured upright orientation of the molecule. 
Solid-state NMR analysis of FML in hydrated vesicles 
The 19F spectrum of FML in POPC bilayers (10:1 drug: lipid 
molar ratio) exhibits an unusual multi-component lineshape 
centred at around 170 ppm (Figure 6a).  The 31P NMR spectrum 
(not shown) is virtually identical to that of the DFP:POPC 
preparation (Figure 2a), indicating that that the bilayer structure is 
retained in the presence of the drug. The spectrum can be 
approximated by two lineshape components (Figure 6a, green 
and orange lines) calculated from the same isotropic chemical 
shift and asymmetry parameter ( = 0, indicating anisotropic 
rotation about a principal axis), but different values of av.  These 
two dynamically averaged values are consistent with two average 
orientations of the drug as defined by angles FR and FR.  The 
uncertainties in the angles defining the two orientations are 
considerable (Figure 6b) but cannot be reduced in the same way 
as for DFP because FML carries only a single fluorine. Taking one  




Figure 6. Proton-decoupled 19F NMR analysis of FML in POPC bilayers. (a) 
Experimental spectrum (black) overlaid with simulated axially symetric line 
shape components (orange and green) correponding to a single isotropic 
chemical shift, i, but different values of the averaged chemical shift anisotropy, 
av. (b) Plot of FR and FR angles consistent with the av values of the two 
components.  The orange and green contours represent av ranges of -8.0 to -
7.0 ppm and 11.0 to 12.0 ppm, respectively. (c) One example of the exchange 
of FML between orientations, defined by [FR, FR] angles that are consistent 
with the NMR data. (d) Refined fit to the experimental spectrum after including 
exchange between the two orientations at a rate constant kexch = 400 s-1 in the 
lineshape simulation.  
possible [FR,FR] combination for each orientation, [0°,29°] and 
[0°,61°] (Figure 6c), it was found that a closer fit to the 
experimental lineshape could obtained by assuming exchange 
between the two orientations (Figure S3).  A flattening of the outer 
wings is seen with increasing exchange rate and a narrow line 
appears at the isotropic chemical shift.  The best fit corresponded 
to an exchange rate constant, kexch, of 400 s-1 (Figure 6d).  
Raman analysis of DFP and FML in dried lipid films 
Figure 7a compares the Raman spectra of POPC 
multilamellar vesicle (MLV) samples prepared as dried films with 
and without DFP (10:1 lipid: drug molar ratio) and the pure 
spectrum of DFP in the fingerprint wavenumber range 850-1800 
cm-1.  The spectrum for DFP is similar to previously reported 
spectra[13] and it was hoped that signature peaks in the range 600-
800 cm-1 corresponding to C-F vibrations could be used to identify 
the drug within the MLV sample, but these were too weak to be of 
value.    Peaks in the region 1600-1680 cm-1 have been assigned 
to ring A C=C and C=O vibrations in the Raman spectrum of the 
related compound cortisone and an intense peak can be observed 
at 1666 cm-1 for pure DFP.[14]  As expected during thin film 
formation, for both the POPC and DFP MLV samples a coffee ring 
effect was observed. [15] In the case of the POPC-only sample, no 
difference in spectra, whether collected from the central region or 
the edge of the film, was observed (see Supplementary 
Information, Figure S4), However, spectra of the POPC-DFP 
sample acquired from the central areas of the film differed from 
those  acquired at the edge (example spectra shown in Figure 7a). 
The average spectrum acquired from the outer edges of the film 
is identical to the spectrum of POPC alone, regardless of position, 
potentially suggesting MLVs without DFP encapsulated have 
diffused to the outer edges of the thin film.   
  The dominating DFP peak observed at 1666 cm-1 is not 
present in POPC-DFP edge spectrum, although a slight shoulder  
 
Figure 7. (a) Average Raman spectra (n=8) of DFP (black), POPC (red) and 
POPC-DFP taken from the thin film edge (cyan) and the central (blue) regions 
in the wavenumber range 800-1800 cm-1. (b) Average Raman spectra (n=8) of 
DFP (black), POPC (red) and POPC-DFP complex (blue) in the wavenumber 
rang 2800-3000 cm-1. (c) Average Raman spectra (n=8) of FML (black), POPC 
(red) and POPC-FML taken from the thin film edge (cyan) and the central (blue) 
regions in the wavenumber range 800-1800 cm-1. (d) Average Raman spectra 
(n=8) of FML (black), POPC (red) and POPC-FML complex (blue) in the 
wavenumber rang 2800-3000 cm-1. 
can be observed in the POPC-DFP centre spectrum it is difficult 
to conclusively determine the presence of DFP from this peak 
alone. An additional peak at 1440 cm-1 assigned to alkyl CH2 
bend[15] can be observed in the DFP only spectrum and may be a 
stronger indicator of the presence of liposome and drug in the 
central region of the film.  A further peak at 1082 cm-1 can only be 
observed in the spectrum of MLVs with DFP encapsulated 
possibly indicating a change in the liposome conformation as they 
are not present in the pure DFP spectrum. The peak at 1082 cm-
1 is assigned to alkyl C-C gauche stretch whilst the peak at 1050 
cm-1 observed in the POPC only spectrum is assigned to the C-C 
trans stretch and have previously been used to assess the phase 
state of constituent lipids.[16] In Figure 7a, the observed intensity  
decrease in the peak a 1050 cm-1 combined with the appearance 
of the peak at 1082 cm-1 potentially indicates a loss of liposome 
order with the addition of DFP, although this could be a combined 
effect of the drug and sample drying, which may destabilise the 
vesicles. Figure 7b compares the Raman spectra of DFP, POPC 
and the POPC with encapsulated DFP MLVs in the higher 
wavenumber range 2800-3000 cm-1. No intense Raman peaks 
can be observed for DFP whilst two intense Raman peaks can be 
observed for the POPC only sample at 2890 cm-1 (CH2 
asymmetric stretch) and 2943 cm-1 (CH3 methyl symmetric 
stretch). Interestingly, the peak observed at 2852 cm-1 (CH2 
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symmetric stretch) in the POPC-DFP sample is far more intense 
compared to the spectrum of POPC only acquired from the dried 
films, with a reduced intensity for the peaks at 2943 cm-1. It has 
previously been  reported that the ratio of intensities between the 
symmetrical and asymmetrical methylene stretch peaks is 
sensitive to intermolecular packing as well as inter-chain 
interactions.[17]  Sassi et. al[18] also reported a similar change in 
peak intensity during heating of phosphatidylcholine assigning 
this to an increase of gauche conformer fraction or a loss of lateral 
packing of the acyl chains.  Consequently, the Raman spectra of 
the POPC-DFP complex compared to POPC alone indicates a 
loss of lateral spacing of the acyl chains in the presence of DFP. 
Figure 7 (panels c and d) compares the Raman spectra of 
POPC MLV samples with and without FML. The FML-only 
spectrum reveals an intense peak at 1655 cm-1 which can be 
observed as a weaker peak in the spectra acquired from the 
centre and edge of the film. Unlike the POPC-DFP spectrum, no 
difference in the spectra is observed between the centre and outer 
regions of the coffee ring, indicating a more homogenous surface.  
When compared to the POPC only spectrum subtle differences 
can be observed in the POPC-FML spectra in the wavenumber 
range 950-1800 cm-1 (Figure 7c). A broad alkyl CH2 peak at 1440 
cm-1  can be observed in the complex spectra shifting from the 
sharper peak at 1463 cm-1 in the POPC only spectrum. As with 
the POPC- DFL complex the C-C stretch assigned peak at 1050 
cm-1 has broadened and shifted to 1082 cm-1 indicating a change 
from trans to gauche confirmation with the addition of FML prior 
to drying.  The appearance of a shoulder can also be observed at 
1310 cm-1. The intensities of peaks in this region are sensitive to 
changes between gauche and trans.[19]  Similarly, in Figure 7d, a 
loss of peak intensity is observed for the CH2 asymmetric stretch 
at 2980 cm-1 and the CH3 methyl stretch with the appearance of 
CH2 symmetric stretch at 2852 cm-1 and 2926 cm-1 suggests that, 
as with DFP, the phospholipid chains are becoming more 
disordered with the addition of FML.   
 
Conclusion 
In this work, Raman and NMR spectroscopy were used to report 
the physical properties of the ocular drugs DFP and FML in 
phospholipid bilayers.  The Raman data suggest that both drugs  
decrease the order of the lipid chains, but the 31P NMR spectra of 
the lipid headgroups of hydrated bilayers indicate that the 
increased disorder does not disrupt the overall bilayer structure.  
The ability of the lipids to accommodate high levels of drug without 
disruption  of the vesicular bilayer structure could be a favourable 
attribute for ocular therapy, where small volumes of liposomes 
may be required to deliver high drug concentrations over a small 
surface area.   
The 19F NMR spectra of the drugs in the hydrated vesicles 
have lineshapes that confirm that the drugs reside fully in the lipid 
bilayer and are not distributed between the lipid and water phases, 
which may have implications for drug release kinetics. A novel 
feature of this work was the ability to determine the average 
orientation of DFP within the lipid bilayer, by exploiting the 
chemical shift and dipolar coupling parameters for the two fluorine 
nuclei in the molecule. The orientational preference of a molecule 
within cell membranes can influence its cellular uptake and may 
also affect its interaction with efflux transporters that export drugs 
from the cell.[20]  
It should be noted that several assumptions are made in 
determining the drug orientation.  The assumed order parameter 
Smol of 0.8, which represents angular excursions of the rotational 
axis away from the bilayer normal, is taken from the value 
obtained for cholesterol in lipid bilayers.  Deviations from this 
value by +/- 0.1 units would affect the range of values of the 
calculated angle  only very slightly and so would not alter the 
determined orientation significantly.  It is also assumed that the 
optimised structure of DFP represents its conformation in the 
membrane. The NMR spectra of the solid drug confirms that it can 
adopt multiple conformations and in the membrane environment 
the drug will sample different ring conformations in dynamic 
equilibrium. The conformational exchange is rapid on the NMR 
time scale and so the spectra reflect the time-averaged 
conformation of the drug. Interestingly, FML adopts two principal 
orientations in the bilayers as compared with the single average 
orientation of DFP.  The ability of FML to adopt two orientations 
may be attributed to the shorter aliphatic tail of the molecule, 
which is less effective at stabilising the molecule in the bilayer 
than are the longer tails of DFP.  
The MLV samples for Raman analysis were dried to produce 
films and this process appears to result in lipid-free POPC 
diffusing away from lipids associated with DFP. By contrast, FML 
remains associated with the lipid across the entire sample. The 
ability of Raman to detect these different physicochemical 
properties of the dried formulations could provide a useful tool for 
drug-liposome quality control, as sample drying during 
formulation is employed to increase the stability of the drug 
product for storage.[21] Air drying or lyophilisation of liposomes in 
the absence of cryoprotectants such as trehalose is known to 
have several effects upon the lipids.[22]  Although a lamellar-like 
structure is preserved, the phase transition temperature increases 
due to increased van der Waals interactions between the lipids 
after removal of water from the headgroup region.  This can cause 
leakage of the drug cargo from liposomes and upon rehydration 
the liposomes can coalesce to form larger structures.[22]  It was 
not possible to visualise the morphology of the dried vesicles on 
the steel slides used for Raman analysis, but analysis of pre-dried 
and rehydrated MLVs by negative-stain transmission electron 
microscopy indicated that the vesicular morphology is preserved 
after drying on carbon-coated copper grids (Figure S5), with a size 
range (< 2 m) that is typical for MLVs. Dehydration damage to 
the MLVs on the steel slides for Raman cannot be ruled out, 
however. That FML, but not DFP, associates uniformly with the 
lipids is surprising because DFP is the more lipophilic drug, having 
a higher logP(octanol/water) (3.4 compared to 2.0).  The extent of 
drug and lipid colocalisation may simply reflect the effectiveness  
with which the drugs stabilise the vesicles during the drying 
process.  Further Raman experiments, beyond the scope of this 
work, could investigate whether cryoprotectants help to maintain 
a uniform distribution of lipids and drug.  
In summary, the combined use of Raman and 19F solid-state 
NMR spectroscopy has revealed insights into the orientation, 
distribution and lipid-chain perturbing effects of a fluorinated 
ocular drug within phospholipid bilayers. The use of 19F NMR is 
attractive because there is no background signal, the spectra can 
be assigned unambiguously to the drug and ~30 % of licensed 
drugs contain one or more fluorine atoms, making the 
methodology widely applicable.  The wealth of information 
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provided by the two techniques combined could be correlated with 
drug release kinetics to optimize the formulation of drug-liposomal 
complexes for delivery to the eye and other tissue.      
Experimental Section 
Preparation of membrane samples 
Solid DFP (Sigma Aldrich) was analysed as received without 
recrystallisation. For vesicle preparation, the compound (5 mg) 
was dissolved in chlorofom: methanol (50:50) with a 10-fold molar 
excess of the lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) and dried to a thin film in a round bottom 
flask under nitrogen and then under high vacuum.  Multilamellar 
vesicles (MLVs) were produced by resuspending the film in water, 
subjecting to 5 freeze-thaw cycles. For Raman spectroscopy 30 
µL of the sample were pipetted onto a stainless-steel slide and 
dried at room temperature. For NMR analysis the samples were 
centrifuged in a bench top centrifuge to remove excess liquid and 
the pellet was transferred to a 3.2 mm diameter zirconium rotor. 
NMR analysis 
All measurements were performed on a Bruker Avance III 
spectrometer with an 89 mm bore magnet operating at 9.3 T, at a 
sample temperature of 30°C. A Bruker quadruple resonance 
(HFXY) magic-angle spinning probe tuned simultaneously to 19F 
and 1H was used for all measurements. The proton-decoupled 19F 
CP-MAS NMR spectrum of solid DFP was obtained with 5 kHz 
sample spinning.  An initial 2.5 s 90° pulse on 1H was followed 
by 2 ms ramped cross-polarization from 1H to 19F at a proton 
nutation frequency of 40 kHz followed by irradiation of protons at 
a field of 83 kHz during signal acquisition.  The spectrum is the 
result of averaging 512 transients with a recycle delay of 5 s. The 
proton-decoupled 19F NMR spectra of the membrane samples 
were obtained with direct excitation of 19F using a 4.2 s 90° pulse.  
The spectrum of the hydrated sample is the result of averaging 
1600 transients with a recycle delay of 2 s. The proton-decoupled 
31P spectra of the membrane samples were obtained in a flat-coil 
probe, with a 4 s 90° pulse followed by signal acquisition with 20 
kHz proton decoupling. 
Computational details 
The principal values of the 19F chemical shift tensor were obtained 
by least-squares fitting of a multi-component simulated spectrum 
using the Bruker Topspin function Sola.  Optimisation of the 
molecular geometry and calculation of the NMR parameters was 
performed using the CASTEP density functional theory code,[23] 
employing the GIPAW algorithm,[24] which allows the 
reconstruction of the all-electron wave function in the presence of 
a magnetic field. The CASTEP density functional theory 
calculations employed the generalised gradient approximation 
(GGA) PBE functional[25] and core–valence interactions were 
described by pseudopotentials.[26] In the geometry optimisation, 
all atomic positions were allowed to vary and the Grimme G06 
semi-empirical dispersion correction scheme was used.[26] 
Calculations were performed using a planewave energy cut-off of 
50 Ry (680 eV) and due to the large cell size, a single k-point at 
the fractional coordinate (0.25, 0.25, 0.25) in reciprocal space for 
integration over the Brillouin zone. The calculations generate the 
absolute shielding tensor () and diagonalisation of the symmetric 
part of  yields as eigenvalues the principal components 11, 22 
and  and their orientations in the molecular frame are given by 
the eigenvectors. 
 The angles defining the orientations of the 19F chemical shift 
tensor and 1H-19F dipolar vectors relative to a given axis of rotation 
were calculated using a C program written specifically for the 
purpose. Briefly, the angles MR and MR defining the orientation 
of the axis of rotation in a fixed molecular reference frame were 
transformed into angles FR and FR defining the orientation of the 
rotation axis relative to the F28 and F29 chemical shift principal 
axes, and angle  defining the orientation relative to each dipolar 
vector. The dynamically averaged chemical shift 
anisotropies, av, for each orientation were calculated according 
to Eq. [1] and compared with the measured values.   The 
difference between the experimental and calculated values were 
calculated as a combined sum-of-squares (SS) from the equation 
𝑆𝑆(𝛼𝑀𝑅 , 𝛽𝑀𝑅) = (𝐶𝐹28 − 𝑀𝐹28)
2 + (𝐶𝐹29 − 𝑀𝐹29)
2     [3] 
where C and M are the calculated and measured values of av 
for F28 and F29.  Values of angles MR and MR were considered 
to be consistent with the data when SS < 5.0 ppm. The proton-
coupled 19F NMR line shapes were simulated using SIMPSON.[27] 
The exchange-modulated lineshape simulations for FML were 
calculated for each orientation in the powder ensemble using the 
Bloch-McConnell approach for each crystallite. 
Raman spectroscopy 
Raman spectra were acquired using a confocal Raman system 
(InVia, Renishaw plc, Wotton-Under edge, UK) coupled to a 785 
nm wavelength laser from 850-3000 cm-1. All spectra was 
acquired using 50x objective with a laser power at the sample of 
~5 mW, exposure time of 10 s. Spectra of DFP were collected 
from the solid sample and the spectra of the membrane samples 
were collected from thin films produced from drying 30 µL pipetted 
onto stainless steel slides. Eight repeat spectra were collected 
and averaged for all samples. Spectral data was divided into the 
two spectral regions of interest 2800-3000 cm-1 and 850-1800 cm-
1 before data processing and analysis. All data processing was 
carried out using Matlab (version R2016a) using in house 
toolboxes. After cosmic spike removal data were normalised 
using standard normal variate (SNV) before smoothing using a 
triangular average.  
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Vibrational Raman and 19F NMR spectroscopy are used to characterize phospholipid vesicles carrying the ocular corticosteroid drugs 
difluprednate (DFP) and fluoromethalone (FML). NMR chemical shift and 19F-1H dipolar couplings are used to determine the average 
orientation of DFP and Raman spectra of dried lipid films reveal that the lipid partially separates from DFP but not from FML, the less 
lipophilic of the two drugs. The combined power of the two techniques in liposomal formulation is demonstrated. 
 
 
